BTS
PFE icon

BB&T Securities’s Pfizer PFE Stock Holding History

BB&T Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$73.4M Buy
2,150,223
+62,309
+3% +$2.27M 0.67% 26
2019
Q2 		$85.8M Buy
2,087,914
+57,541
+3% +$2.28M 0.78% 15
2019
Q1 		$81.8M Sell
2,030,373
-72,520
-3% -$2.9M 0.79% 13
2018
Q4 		$87.1M Sell
2,102,893
-256,396
-11% -$10.6M 0.96% 7
2018
Q3 		$98.6M Sell
2,359,289
-25,479
-1% -$981K 0.97% 5
2018
Q2 		$82.1M Buy
2,384,768
+84,485
+4% +$2.89M 0.87% 7
2018
Q1 		$77.5M Buy
2,300,283
+35,807
+2% +$1.23M 0.88% 8
2017
Q4 		$77.8M Buy
2,264,476
+81,603
+4% +$2.78M 1.01% 5
2017
Q3 		$73.9M Sell
2,182,873
-21,307
-1% -$685K 1.01% 5
2017
Q2 		$70.2M Sell
2,204,180
-619,153
-22% -$19.5M 1.02% 6
2017
Q1 		$91.6M Sell
2,823,333
-23,785
-0.8% -$750K 1.25% 5
2016
Q4 		$90.4M Buy
2,847,118
+114,658
+4% +$3.5M 1.31% 4
2016
Q3 		$87.8M Buy
2,732,460
+294,473
+12% +$9.85M 1.31% 4
2016
Q2 		$81.4M Sell
2,437,987
-37,646
-2% -$1.2M 1.26% 6
2016
Q1 		$69.6M Buy
2,475,633
+696,595
+39% +$19.9M 1.14% 9
2015
Q4 		$54.5M Buy
1,779,038
+13,002
+0.7% +$409K 1.14% 10
2015
Q3 		$52.6M Sell
1,766,036
-16,988
-1% -$545K 1.16% 12
2015
Q2 		$56.7M Sell
1,783,024
-36,958
-2% -$1.2M 1.2% 12
2015
Q1 		$60.1M Sell
1,819,982
-74,303
-4% -$2.36M 1.32% 8
2014
Q4 		$56M Sell
1,894,285
-55,798
-3% -$1.6M 1.26% 11
2014
Q3 		$54.7M Sell
1,950,083
-48,900
-2% -$1.37M 1.28% 13
2014
Q2 		$56.3M Buy
1,998,983
+89,664
+5% +$2.56M 1.34% 13
2014
Q1 		$58.2M Sell
1,909,319
-84,317
-4% -$2.51M 1.51% 5
2013
Q4 		$57.9M Buy
1,993,636
+23,463
+1% +$683K 1.6% 2
2013
Q3 		$53.7M Buy
1,970,173
+54,502
+3% +$1.48M 1.66% 3
2013
Q2 		$50.9M Buy
+1,915,671
New +$52.9M 1.66% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BB&T Securities's PFE Position: Q3 2019 in Review

BB&T Securities increased its Pfizer (PFE) stake by 3% in Q3 2019, buying an estimated $2.27M and bringing the position to 2,150,223 shares worth $73.4M. The position accounts for 0.67% of the portfolio, ranked #26.

BB&T Securities first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $98.6M in Q3 2018. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • BB&T Securities held 2,150,223 shares of Pfizer worth $73.4M as of Q3 2019.
  • BB&T Securities bought 62,309 Pfizer shares in Q3 2019, an estimated $2.27M.
  • Pfizer made up 0.67% of BB&T Securities's portfolio in Q3 2019, its #26 holding.
  • BB&T Securities first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's Pfizer position peaked at $98.6M in Q3 2018.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.